Gagnon Advisors’s Apollo Endosurgery, Inc. APEN Stock Holding History

Gagnon Advisors’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,329,354	Closed	-$13.3M	–	29
2022 Q4	$13.3M	Hold	1,329,354	–	–	8.95%	1
2022 Q3	$7.33M	Hold	1,329,354	–	–	4.74%	8
2022 Q2	$4.85M	Hold	1,329,354	–	–	2.94%	15
2022 Q1	$8.04M	Hold	1,329,354	–	–	3.71%	12
2021 Q4	$11.2M	Hold	1,329,354	–	–	4.45%	9
2021 Q3	$12M	Hold	1,329,354	–	–	4.78%	8
2021 Q2	$10.8M	Buy	1,329,354 +128,585	+11%	+$882K	4.09%	8
2021 Q1	$6.62M	Hold	1,200,769	–	–	2.72%	15
2020 Q4	$4.08M	Buy	1,200,769 +280,923	+31%	+$740K	1.84%	21
2020 Q3	$1.55M	Buy	919,846 +400,000	+77%	+$603K	0.95%	27
2020 Q2	$850K	Hold	519,846	–	–	0.61%	25
2020 Q1	$998K	Hold	519,846	–	–	0.93%	23
2019 Q4	$1.48M	Hold	519,846	–	–	0.83%	27
2019 Q3	$1.71M	Hold	519,846	–	–	1.06%	28
2019 Q2	$1.69M	Hold	519,846	–	–	0.96%	29
2019 Q1	$1.94M	Hold	519,846	–	–	1.11%	28
2018 Q4	$1.79M	Buy	519,846 +268,790	+107%	+$1.33M	1.26%	26
2018 Q3	$1.8M	Hold	251,056	–	–	1.08%	26
2018 Q2	$1.75M	Buy	+251,056	New	+$1.56M	1.11%	26

Other funds holding APEN

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Gagnon Advisors's APEN Position: Q1 2023 in Review

Gagnon Advisors sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2023, closing a stake of 1,329,354 shares — an estimated $13.3M sold.

Gagnon Advisors first reported a position in APEN in Q2 2018 and held it in 19 quarters. The position peaked at $13.3M in Q4 2022. 89 funds tracked by Wall St. Rank hold APEN as of Q1 2023.

Gagnon Advisors reported no remaining Apollo Endosurgery, Inc. position as of Q1 2023 after selling out during the quarter.
Gagnon Advisors sold 1,329,354 Apollo Endosurgery, Inc. shares in Q1 2023, an estimated $13.3M.
Gagnon Advisors first reported a position in Apollo Endosurgery, Inc. in Q2 2018 and held it in 19 quarters.
Gagnon Advisors's Apollo Endosurgery, Inc. position peaked at $13.3M in Q4 2022.
89 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2023.

Based on Gagnon Advisors's 13F filing for Q1 2023, filed 10 Apr 2023.